Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | tissue type plasminogen activator | 0.1104 | 0.8048 | 0.5 |
Echinococcus multilocularis | tissue type plasminogen activator | 0.1104 | 0.8048 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0691 | 0.1785 | 0.1785 |
Brugia malayi | Kringle domain containing protein | 0.1104 | 0.8048 | 0.8048 |
Onchocerca volvulus | 0.109 | 0.7831 | 0.7831 | |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.1104 | 0.8048 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1104 | 0.8048 | 0.8048 |
Onchocerca volvulus | 0.109 | 0.7831 | 0.7831 | |
Leishmania major | hypothetical protein, conserved | 0.1104 | 0.8048 | 0.5 |
Loa Loa (eye worm) | DOMON domain-containing protein | 0.109 | 0.7831 | 0.7831 |
Brugia malayi | Protein kinase domain containing protein | 0.1104 | 0.8048 | 0.8048 |
Toxoplasma gondii | kringle domain-containing protein | 0.1104 | 0.8048 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.1104 | 0.8048 | 0.5 |
Onchocerca volvulus | 0.109 | 0.7831 | 0.7831 | |
Loa Loa (eye worm) | hypothetical protein | 0.109 | 0.7831 | 0.7831 |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.1104 | 0.8048 | 0.5 |
Onchocerca volvulus | 0.109 | 0.7831 | 0.7831 | |
Brugia malayi | SEA domain containing protein | 0.109 | 0.7831 | 0.7831 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.1104 | 0.8048 | 0.8048 |
Schistosoma mansoni | hypothetical protein | 0.109 | 0.7831 | 0.9673 |
Onchocerca volvulus | 0.1104 | 0.8048 | 0.8048 | |
Schistosoma mansoni | hypothetical protein | 0.1104 | 0.8048 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.